NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Joyce Liu¹, Andrew Berchuck², Floor J Backes³, Joshua Cohen⁴, Rachel Grisham⁵, Charles A Leath⁶, Lainie Martin⁷, Daniela Matei⁸, David S Miller⁹, Sharon Robertson¹⁰, Lisa Barroilhet¹¹, Shitanshu Uppal¹², Andrea Wahner Hendrickson¹³, David M Gershenson¹⁴, Heidi J Gray¹⁵, Ardeshir Hakam¹⁶, Angela Jain¹⁷, Gottfried E Konecny¹⁸, John Moroney¹⁹, Elena Ratner²⁰, John Schorge²¹, Premal H Thaker²², Theresa L Werner²³, Emese Zsiros²⁴, Kian Behbakht²⁵, Lee-May Chen²⁶, Marie DeRosa²⁷, Eric L Eisenhauer²⁸, Gary Leiserowitz²⁹, Babak Litkouhi³⁰, Michael McHale³¹, Sanja Percac-Lima²⁸, Kerry Rodabaugh³², Roberto Vargas³³, Frankie Jones³⁴, Emily Kovach³⁴, Lisa Hang³⁴, Swathi Ramakrishnan³⁴, Ronald D Alvarez³⁵, Deborah K Armstrong³⁶

Affiliations

¹ Dana-Farber/Brigham and Women's Cancer Center.
² Duke Cancer Institute.
³ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
⁴ City of Hope National Medical Center.
⁵ Memorial Sloan Kettering Cancer Center.
⁶ O'Neal Comprehensive Cancer Center at UAB.
⁷ Abramson Cancer Center at the University of Pennsylvania.
⁸ Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
⁹ UT Southwestern Simmons Comprehensive Cancer Center.
¹⁰ Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
¹¹ University of Wisconsin Carbone Cancer Center.
¹² University of Michigan Rogel Cancer Center.
¹³ Mayo Clinic Comprehensive Cancer Center.
¹⁴ The University of Texas MD Anderson Cancer Center.
¹⁵ Fred Hutch Cancer Center.
¹⁶ Moffitt Cancer Center.
¹⁷ Fox Chase Cancer Center.
¹⁸ UCLA Jonsson Comprehensive Cancer Center.
¹⁹ The UChicago Medicine Comprehensive Cancer Center.
²⁰ Yale Cancer Center/Smilow Cancer Hospital.
²¹ St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
²² Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
²³ Huntsman Cancer Institute at the University of Utah.
²⁴ Roswell Park Comprehensive Cancer Center.
²⁵ University of Colorado Cancer Center.
²⁶ UCSF Helen Diller Family Comprehensive Cancer Center.
²⁷ Patient Advocate.
²⁸ Mass General Cancer Center.
²⁹ UC Davis Comprehensive Cancer Center.
³⁰ Stanford Cancer Institute.
³¹ UC San Diego Moores Cancer Center.
³² Fred & Pamela Buffett Cancer Center.
³³ Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
³⁴ National Comprehensive Cancer Network.
³⁵ Vanderbilt-Ingram Cancer Center.
³⁶ Johns Hopkins Kimmel Cancer Center.

PMID: 39413835
DOI: 10.6004/jnccn.2024.0052

Practice Guideline

NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Joyce Liu et al. J Natl Compr Canc Netw. 2024 Oct.

. 2024 Oct;22(8):512-519.

doi: 10.6004/jnccn.2024.0052.

Authors

Affiliations

¹ Dana-Farber/Brigham and Women's Cancer Center.
² Duke Cancer Institute.
³ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
⁴ City of Hope National Medical Center.
⁵ Memorial Sloan Kettering Cancer Center.
⁶ O'Neal Comprehensive Cancer Center at UAB.
⁷ Abramson Cancer Center at the University of Pennsylvania.
⁸ Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
⁹ UT Southwestern Simmons Comprehensive Cancer Center.
¹⁰ Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
¹¹ University of Wisconsin Carbone Cancer Center.
¹² University of Michigan Rogel Cancer Center.
¹³ Mayo Clinic Comprehensive Cancer Center.
¹⁴ The University of Texas MD Anderson Cancer Center.
¹⁵ Fred Hutch Cancer Center.
¹⁶ Moffitt Cancer Center.
¹⁷ Fox Chase Cancer Center.
¹⁸ UCLA Jonsson Comprehensive Cancer Center.
¹⁹ The UChicago Medicine Comprehensive Cancer Center.
²⁰ Yale Cancer Center/Smilow Cancer Hospital.
²¹ St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
²² Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
²³ Huntsman Cancer Institute at the University of Utah.
²⁴ Roswell Park Comprehensive Cancer Center.
²⁵ University of Colorado Cancer Center.
²⁶ UCSF Helen Diller Family Comprehensive Cancer Center.
²⁷ Patient Advocate.
²⁸ Mass General Cancer Center.
²⁹ UC Davis Comprehensive Cancer Center.
³⁰ Stanford Cancer Institute.
³¹ UC San Diego Moores Cancer Center.
³² Fred & Pamela Buffett Cancer Center.
³³ Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
³⁴ National Comprehensive Cancer Network.
³⁵ Vanderbilt-Ingram Cancer Center.
³⁶ Johns Hopkins Kimmel Cancer Center.

PMID: 39413835
DOI: 10.6004/jnccn.2024.0052

Abstract

The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.

PubMed Disclaimer

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Sheridan PubFactory
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Affiliations

NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical